Hyperprolactinemia and gonadal dysfunction represent potentially relevant non-traditional cardiovascular risk factors in CKD and dialysis populations and their integration within the broader neuroendocrine-cardiovascular axis provides a novel pathophysiological framework linking endocrine abnormalities, uremic toxicity...
Vincenzo Barbera, L. Di Lullo, Antonio Bellasi et al.· CardioRenal Medicine· 0 citations
Chronic kidney disease (CKD) represents a clinically relevant setting in which Lp(a) levels may rise as renal function declines, contributing to the excess cardiovascular burden and residual risk left unaddressed by historical statin trials in the end-stage renal disease population.
L. Di Lullo, Paola Peverini, Antonio Bellasi et al.· CardioRenal Medicine· 0 citations
Therapeutic management becomes increasingly complex in advanced CKD, where fracture risk is high, and evidence for osteoporosis treatments is limited, and evidence for osteoporosis treatments is limited.
Giuseppe Cianciolo, Antonio Bellasi, Sandro Giannini et al.· Kidney360· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.